Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StockTalk | Cannabis Report: Quarterly report season rolls on

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| February 7, 2025

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlarge
(Source: Aurora Cannabis)

A global cannabis stock released its financial and operational results for Q3 fiscal 2025, showing growth and profitability improvements across its business segments. The company anticipates continued revenue growth across its cannabis business, supported by year-over-year growth in international medical cannabis.

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | 1933 Industries appoints new CFO and VP finance

2 | Curaleaf launches ‘Reef’ flower brand in Florida

3 | Tilray subsidiary partners with JetBlue to make Montauk beer available to customers on all domestic and international flights

4 | Canopy Growth Reports Q3 fiscal 2025 financial results

Click to enlarge

Top Cannabis Stocks Jan. 31 to Feb. 6, 2025

1. T.TLRY | 7,866 views | Tilray Brands Inc.
2. C.CURA | 5,421 views | Curaleaf Holdings Inc.
3.T.WEED | 3,674 views | Canopy Growth Corp.
4. T.LABS | 2,455 views | Medipharm Labs Corp.
5. C.OILS | 700 views | Nextleaf Solutions Inc.
6. C.TGIF | 459 views | 1933 Industries Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}